Filing Details

Accession Number:
0001968202-23-000042
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-15 16:02:48
Reporting Period:
2023-11-13
Accepted Time:
2023-11-15 16:02:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc. REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1796226 J Andrew Murphy 777 Old Saw Mill River Road
Tarrytown NY 10591
Evp Research No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-11-13 20,000 $270.43 79,421 No 4 M Direct
Common Stock Disposition 2023-11-13 13,508 $795.69 65,913 No 4 F Direct
Common Stock Disposition 2023-11-14 752 $794.57 65,161 No 4 S Direct
Common Stock Disposition 2023-11-14 347 $795.38 64,814 No 4 S Direct
Common Stock Disposition 2023-11-14 204 $797.79 64,610 No 4 S Direct
Common Stock Disposition 2023-11-14 1,614 $798.63 62,996 No 4 S Direct
Common Stock Disposition 2023-11-14 1,601 $799.48 61,395 No 4 S Direct
Common Stock Disposition 2023-11-14 382 $800.55 61,013 No 4 S Direct
Common Stock Disposition 2023-11-14 877 $801.56 60,136 No 4 S Direct
Common Stock Disposition 2023-11-14 347 $802.63 59,789 No 4 S Direct
Common Stock Disposition 2023-11-14 330 $803.38 59,459 No 4 S Direct
Common Stock Disposition 2023-11-14 19 $804.89 59,440 No 4 S Direct
Common Stock Disposition 2023-11-14 19 $805.00 59,421 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2023-11-13 20,000 $0.00 20,000 $270.43
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,000 2023-12-13 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,310 Indirect By 401(k) Plan
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 9, 2023.
  2. Represents volume-weighted average price of sales of 752 shares of Company stock on November 14, 2023 at prices ranging from $794.03 to $794.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price.
  3. Represents volume-weighted average price of sales of 347 shares of Company stock on November 14, 2023 at prices ranging from $795.02 to $795.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price.
  4. Represents volume-weighted average price of sales of 204 shares of Company stock on November 14, 2023 at prices ranging from $797.09 to $797.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price.
  5. Represents volume-weighted average price of sales of 1,614 shares of Company stock on November 14, 2023 at prices ranging from $798.00 to $798.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price.
  6. Represents volume-weighted average price of sales of 1,601 shares of Company stock on November 14, 2023 at prices ranging from $799.00 to $799.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price.
  7. Represents volume-weighted average price of sales of 382 shares of Company stock on November 14, 2023 at prices ranging from $800.31 to $800.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price.
  8. Represents volume-weighted average price of sales of 877 shares of Company stock on November 14, 2023 at prices ranging from $801.01 to $801.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price.
  9. Represents volume-weighted average price of sales of 347 shares of Company stock on November 14, 2023 at prices ranging from $802.17 to $802.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price.
  10. Represents volume-weighted average price of sales of 330 shares of Company stock on November 14, 2023 at prices ranging from $803.18 to $803.69. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price.
  11. The stock option award vests in four equal annual installments, commencing one year after the date of grant.